WASHINGTON, D.C. - (Mealey's) A shareholder plaintiff and
a pharmaceutical company debated in front of the U.S. Supreme Court on Nov. 5 whether
a securities lawsuit may proceed as a class action even if the plaintiff is
unable to plead materiality ( Amgen Inc., Kevin W. Sharer, Richard D. Nanula...
In a much anticipated ruling in the Amgen securities
class action litigation, the U.S. Supreme Court, in a 6-3 majority opinion
written by Justice Ginsburg, held that a securities plaintiff is not required
to prove that the allegedly misleading statements are material as a
prerequisite to class certification...